Washington Trust Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63K Buy
+120
New +$1.44K ﹤0.01% 648
2023
Q1
Sell
-30
Closed -$838 789
2022
Q4
$838 Sell
30
-149
-83% -$3.81K ﹤0.01% 769
2022
Q3
$4K Buy
179
+1
+0.6% +$30 ﹤0.01% 762
2022
Q2
$6K Sell
178
-329
-65% -$11.5K ﹤0.01% 720
2022
Q1
$18K Sell
507
-74
-13% -$2.53K ﹤0.01% 614
2021
Q4
$18K Buy
+581
New +$18.9K ﹤0.01% 644

Other funds holding OGN

Washington Trust Advisors's OGN Position: Q2 2026 in Review

Washington Trust Advisors opened a new position in Organon & Co (OGN) in Q2 2026: 120 shares worth $1.63K. The stake represents ﹤0.01% of the portfolio and ranks #648 among its holdings. This is a return to the name: Washington Trust Advisors previously reported a position in OGN as recently as Q4 2022.

Washington Trust Advisors first reported a position in OGN in Q4 2021 and has held it in 6 quarters since. The position peaked at $18K in Q1 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Washington Trust Advisors held 120 shares of Organon & Co worth $1.63K as of Q2 2026.
  • Organon & Co was a new Washington Trust Advisors position in Q2 2026.
  • Organon & Co made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #648 holding.
  • Washington Trust Advisors first reported a position in Organon & Co in Q4 2021 and has held it in 6 quarters since.
  • Washington Trust Advisors's Organon & Co position peaked at $18K in Q1 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.